209 related articles for article (PubMed ID: 31741306)
1. Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India.
Bahuguna P; Prinja S; Lahariya C; Dhiman RK; Kumar MP; Sharma V; Aggarwal AK; Bhaskar R; De Graeve H; Bekedam H
Appl Health Econ Health Policy; 2020 Jun; 18(3):393-411. PubMed ID: 31741306
[TBL] [Abstract][Full Text] [Related]
2. Safety-Engineered Syringes: An Intervention to Decrease Hepatitis C Burden in Developing Countries-A Cost-Effectiveness Analysis From Egypt.
Mostafa A; El-Sayed MH; El Kassas M; Elhamamsy M; Elsisi GH
Value Health Reg Issues; 2019 Sep; 19():51-58. PubMed ID: 31002984
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Temozolamide for Treatment of Glioblastoma Multiforme in India.
Gupta N; Prinja S; Patil V; Bahuguna P
JCO Glob Oncol; 2021 Jan; 7():108-117. PubMed ID: 33449801
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program.
Prinja S; Bahuguna P; Faujdar DS; Jyani G; Srinivasan R; Ghoshal S; Suri V; Singh MP; Kumar R
Cancer; 2017 Sep; 123(17):3253-3260. PubMed ID: 28472550
[TBL] [Abstract][Full Text] [Related]
5. Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation.
Hancock E; Ward Z; Ayres R; Neale J; Hussey D; Kesten JM; Hickman M; Vickerman P
Addiction; 2020 Apr; 115(4):702-713. PubMed ID: 31633849
[TBL] [Abstract][Full Text] [Related]
6. Cost Effectiveness of Implementing Integrated Management of Neonatal and Childhood Illnesses Program in District Faridabad, India.
Prinja S; Bahuguna P; Mohan P; Mazumder S; Taneja S; Bhandari N; van den Hombergh H; Kumar R
PLoS One; 2016; 11(1):e0145043. PubMed ID: 26727369
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Autologous Stem Cell Treatment as Compared to Conventional Chemotherapy for Treatment of Multiple Myeloma in India.
Prinja S; Kaur G; Malhotra P; Jyani G; Ramachandran R; Bahuguna P; Varma S
Indian J Hematol Blood Transfus; 2017 Mar; 33(1):31-40. PubMed ID: 28194053
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of policies for the safe and appropriate use of injection in healthcare settings.
Dziekan G; Chisholm D; Johns B; Rovira J; Hutin YJ
Bull World Health Organ; 2003; 81(4):277-85. PubMed ID: 12764494
[TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
10. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
11. Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India.
Chugh Y; Dhiman RK; Premkumar M; Prinja S; Singh Grover G; Bahuguna P
PLoS One; 2019; 14(8):e0221769. PubMed ID: 31465503
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of uterine balloon tamponade devices in managing atonic post-partum hemorrhage at public health facilities in India.
Joshi BN; Shetty SS; Moray KV; Sachin O; Chaurasia H
PLoS One; 2021; 16(8):e0256271. PubMed ID: 34407132
[TBL] [Abstract][Full Text] [Related]
13. A cost-effectiveness analysis of the use of safety-engineered syringes in reducing HBV, HCV, and HIV burden in Egypt.
Mostafa A; Elsisi GH
Expert Rev Med Devices; 2019 Feb; 16(2):155-163. PubMed ID: 30571154
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Combined Sexual and Injection Risk Reduction Interventions among Female Sex Workers Who Inject Drugs in Two Very Distinct Mexican Border Cities.
Burgos JL; Patterson TL; Graff-Zivin JS; Kahn JG; Rangel MG; Lozada MR; Staines H; Strathdee SA
PLoS One; 2016; 11(2):e0147719. PubMed ID: 26890001
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment.
Goel A; Chen Q; Chhatwal J; Aggarwal R
J Gastroenterol Hepatol; 2018 Dec; 33(12):2029-2036. PubMed ID: 29864213
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of population-based screening for diabetes and hypertension in India: an economic modelling study.
Kaur G; Chauhan AS; Prinja S; Teerawattananon Y; Muniyandi M; Rastogi A; Jyani G; Nagarajan K; Lakshmi P; Gupta A; Selvam JM; Bhansali A; Jain S
Lancet Public Health; 2022 Jan; 7(1):e65-e73. PubMed ID: 34774219
[TBL] [Abstract][Full Text] [Related]
17. Safety engineered injection devices for intramuscular, subcutaneous and intradermal injections in healthcare delivery settings: a systematic review and meta-analysis.
Harb AC; Tarabay R; Diab B; Ballout RA; Khamassi S; Akl EA
BMC Nurs; 2015; 14():71. PubMed ID: 26722224
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India.
Gupta N; Verma RK; Prinja S; Dhiman RK
J Clin Exp Hepatol; 2019; 9(4):468-475. PubMed ID: 31516263
[TBL] [Abstract][Full Text] [Related]
19. Estimating the Burden of Disease from Unsafe Injections in India: A Cost-benefit Assessment of the Auto-disable Syringe in a Country with Low Blood-borne Virus Prevalence.
Reid S
Indian J Community Med; 2012 Apr; 37(2):89-94. PubMed ID: 22654281
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
Mafirakureva N; Mapako T; Khoza S; Emmanuel JC; Marowa L; Mvere D; Postma MJ; van Hulst M
Transfusion; 2016 Dec; 56(12):3101-3111. PubMed ID: 27696441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
